First dengue vaccine to enter paediatric clinical study
This article was originally published in Scrip
Executive Summary
Sanofi Pasteur's (Sanofi-Aventis) tetravalent dengue vaccine is entering a paediatric clinical study in Thailand to assess its efficacy in protecting children , the company has announced. It is the first vaccine of this type to reach this stage of clinical development, says the company.